Immunization with mimotopes prevents growth of carcinoembryonic antigen-positive tumors in BALB/c mice

Clinical Cancer Research

Volumn 13, Issue 21, 2007, Pages 6501-6508

  Brämswig, Kira H ^a   Knittelfelder, Regina ^a   Gruber, Silke ^a   Untersmayr, Eva ^a   Riemer, Angelika B ^a,b   Szalai, Krisztina ^a   Horvat, Reinhard ^a   Kammerer, Robert ^c   Zimmermann, Wolfgang ^c   Zielinski, Christoph C ^a   Scheiner, Otto ^a   Jensen Jarolim, Erika ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; GLYCOPROTEIN; MULTIPLE ANTIGENIC MIMOTOPE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BAGG ALBINO MOUSE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL STRAIN HT29; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; DRUG DESIGN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; IMMUNE SYSTEM; IMMUNOTHERAPY; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; NEOPLASM TRANSPLANTATION; PEPTIDE LIBRARY; PEPTIDES; PHYLOGENY;

EID: 35948976956     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0692     Document Type: Article

References (35)

1. Pardoll DM. Cancer vaccines. Nat Med 1998;4:525-31.
2. Coligan JE, Lautenschleger JT, Egan ML, Todd CW. Isolation and characterization of carcinoembryonic antigen. Immunochemistry 1972;9:377-86.
3. Pugh CW, Chang GW, Cockman M, et al. Regulation of gene expression by oxygen levels in mammalian cells. Adv Nephrol Necker Hosp 1999;29:191-206.
4. Gold P, Shuster J, Freedman SO. Carcinoembryonic antigen (CEA) in clinical medicine: historical perspectives, pitfalls and projections. Cancer 1978;42:1399-405.
5. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965;121:439-62.
6. Huang EH, Kaufman HL. CEA-based vaccines. Expert Rev Vaccines 2002;1:49-63.
7. Boucher D, Cournoyer D, Stanners CP, Fuks A. Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res 1989;49:847-52.
8. Berinstein NL. Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review. J Clin Oncol 2002;20:2197-207.
9. 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results. J Clin Oncol 2005;23:6763-70.
10. Gillies SD, Lo KM, Wesolowski J. High-level expression of chimeric antibodies using adapted cDNA variable region cassettes. J Immunol Methods 1989;125:191-202.
11. Handgretinger R, Anderson K, Lang P, et al. A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. Eur J Cancer 1995;31A:261-7.
12. Sato JD, Kawamoto T, Le AD, Mendelsohn J, Polikoff J, Sato GH. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med 1983;1:511-29.
13. Goldstein NI, Prewett M, Zuklys K, Rockwell P, Mendelsohn J. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin Cancer Res 1995;1:1311-8.
14. Jager D, Jager E, Knuth A. Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J Clin Pathol 2001;54:669-74.
15. Riemer AB, Klinger M, Wagner S, et al. Generation of Peptidemimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu. J Immunol 2004;173:394-401.
16. Riemer AB, Kurz H, Klinger M, Scheiner O, Zielinski CC, Jensen-Jarolim E. Vaccination with cetuximab mimotopes and biological properties of induced antiepidermal growth factor receptor antibodies. J Natl Cancer Inst 2005;97:1663-70.
17. Riemer AB, Forster-Waldl E, Bramswig KH, et al. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes. Eur J Immunol 2006;36:1267-74.
18. Mazzucchelli L, Burritt JB, Jesaitis AJ, et al. Cell-specific peptide binding by human neutrophils. Blood 1999;93:1738-48.
19. Parmley SF,Smith GP. Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 1988;73:305-18.
20. Barbas CF III, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries onphage surfaces: the gene III site. Proc Natl Acad Sci U S A 1991;88:7978-82.
21. Tam JP. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci U S A 1988;85:5409-13.
22. Boeckler C, Dautel D, Schelte P, et al. Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes. Eur J Immunol 1999;29:2297-308.
23. + T cells to tumor cell antigens by dendritic cells. J Immunol 2002;168:108-17.
24. Qu Z, Griffiths GL, Wegener WA, et al. Development of humanized antibodies as cancer therapeutics. Methods 2005;36:84-95.
25. 131I for use in radioimmunotherapy. J Nucl Med 2005;46:153-9.
26. Blumenthal RD, Osorio L, Hayes MK, Horak ID, Hansen HJ, Goldenberg DM. Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograft. Cancer Immunol Immunother 2005;54:315-27.
27. Stein R, Goldenberg DM. A humanized monoclonal antibody to carcinoembryonic antigen, labetuzumab, inhibits tumor growth and sensitizes human medullary thyroid cancer xenografts to dacarbazine chemotherapy. Mol Cancer Ther 2004;3:1559-64.
28. Kieber-Emmons T, Luo P, Qiu J, et al. Peptide mimicry of adenocarcinoma-associated carbohydrate antigens. Hybridoma 1997;16:3-10.
29. Agadjanyan M, Luo P, Westerink MA, et al. Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus. Nat Biotechnol 1997;15:547-51.
30. Kieber-Emmons T, Luo P, Qiu J, et al. Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses. Nat Biotechnol 1999;17:660-5.
31. Förster-Waldl E, Riemer AB, Dehof AK, et al. Isolation and structural analysis of peptide mimotopes for the disialoganglioside GD2, a neuroblastoma tumor antigen. Mol Immunol 2005;42:319-25.
32. Shi ZR, Tacha D, Itzkowitz SH. Monoclonal antibody COL-1 reacts with restricted epitopes on carcinoembryonic antigen: an immunohistochemical study. J Histochem Cytochem 1994;42:1215-9.
33. Ohuchi N, Wunderlich D, Fujita J, et al. Differential expression of carcinoembryonic antigen in early gastric adenocarcinomas versus benign gastric lesions defined by monoclonal antibodies reactive with restricted antigen epitopes. Cancer Res 1987;47:3565-71.
34. Muraro R, Wunderlich D, Thor A, et al. Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res 1985;45:5769-80.
35. Schöll I, Wiedermann U, Forster-Waldl E, et al. Phage-displayed Bet mim 1, a mimotope of the major birch pollen allergen Bet v 1, induces B cell responses to the natural antigen using bystander T cell help. Clin Exp Allergy 2002;32:1583-8.